Well, I seem to have goofed. When I posted the version of the Udall
Bill as incorporated into the larger appropriations HR2264 bill as
an amendment, as I fouund it in http://thomas.loc.gov (the version
sent to the President.), I hadn't seen the "page forward" thing to
click on, so I omItted the last few paragraphs. Here's the whole
thing:
TITLE VI--OTHER PROVISIONS
PARKINSON'S DISEASE RESEARCH
SEC. 603. (a) SHORT TITLE- This section may be cited as the
`Morris K. Udall Parkinson's Disease Research Act of 1997'.
(b) FINDING AND PURPOSE-
(1) FINDING- Congress finds that to take full advantage of
the tremendous potential for finding a cure or effective
treatment, the Federal investment in Parkinson's disease must
be expanded, as well as the coordination strengthened among the
National Institutes of Health research institutes.
(2) PURPOSE- It is the purpose of this section to provide for
the expansion and coordination of research regarding
Parkinson's disease, and to improve care and assistance for
afflicted individuals and their family caregivers.
(c) PARKINSON'S DISEASE RESEARCH- Part B of title IV of the
Public Health Service Act (42 U.S.C. 284 et seq.) is amended by
adding at the end the following:
`PARKINSON'S DISEASE
`SEC. 409B. (a) IN GENERAL- The Director of NIH shall establish a
program for the conduct and support of research and training with
respect to Parkinson's disease (subject to the extent of amounts
appropriated under subsection (e)).
`(b) INTER-INSTITUTE COORDINATION-
`(1) IN GENERAL- The Director of NIH shall provide for the
coordination of the program established under subsection (a)
among all of the national research institutes conducting
Parkinson's disease research.
`(2) CONFERENCE- Coordination under paragraph (1) shall
include the convening of a research planning conference not
less frequently than once every 2 years. Each such conference
shall prepare and submit to the Committee on Appropriations and
the Committee on Labor and Human Resources of the Senate and
the Committee on Appropriations and the Committee on Commerce
of the House of Representatives a report concerning the
conference.
`(c) MORRIS K. UDALL RESEARCH CENTERS-
`(1) IN GENERAL- The Director of NIH is authorized to award
Core Center Grants to encourage the development of innovative
multidisciplinary research and provide training concerning
Parkinson's disease. The Director is authorized to award not
more than 10 Core Center Grants and designate each center
funded under such grants as a Morris K. Udall Center for
Research on Parkinson's Disease.
`(2) REQUIREMENTS-
`(A) IN GENERAL- With respect to Parkinson's disease,
each center assisted under this subsection shall--
`(i) use the facilities of a single institution or a
consortium of cooperating institutions, and meet such
qualifications as may be prescribed by the Director of
the NIH; and
`(ii) conduct basic and clinical research.
`(B) DISCRETIONARY REQUIREMENTS- With respect to
Parkinson's disease, each center assisted under this
subsection may--
`(i) conduct training programs for scientists and
health professionals;
`(ii) conduct programs to provide information and
continuing education to health professionals;
`(iii) conduct programs for the dissemination of
information to the public;
`(iv) separately or in collaboration with other
centers, establish a nationwide data system derived
from patient populations with Parkinson's disease, and
where possible, comparing relevant data involving
general populations;
`(v) separately or in collaboration with other
centers, establish a Parkinson's Disease Information
Clearinghouse to facilitate and enhance knowledge and
understanding of Parkinson's disease; and
`(vi) separately or in collaboration with other
centers, establish a national education program that
fosters a national focus on Parkinson's disease and the
care of those with Parkinson's disease.
`(3) STIPENDS REGARDING TRAINING PROGRAMS- A center may use
funds provided under paragraph (1) to provide stipends for
scientists and health professionals enrolled in training
programs under paragraph (2)(B).
`(4) DURATION OF SUPPORT- Support of a center under this
subsection may be for a period not exceeding five years. Such
period may be extended by the Director of NIH for one or more
additional periods of not more than five years if the
operations of such center have been reviewed by an appropriate
technical and scientific peer review group established by the
Director and if such group has recommended to the Director that
such period should be extended.
`(d) MORRIS K. UDALL AWARDS FOR EXCELLENCE IN PARKINSON'S DISEASE
RESEARCH- The Director of NIH is authorized to establish a grant
program to support investigators with a proven record of
excellence and innovation in Parkinson's disease research and who
demonstrate potential for significant future breakthroughs in the
understanding of the pathogensis, diagnosis, and treatment of
Parkinson's disease. Grants under this subsection shall be
available for a period of not to exceed 5 years.
`(e) AUTHORIZATION OF APPROPRIATIONS- For the purpose of carrying
out this section and section 301 and title IV of the Public Health
Service Act with respect to research focused on Parkinson's
disease, there are authorized to be appropriated up to
$100,000,000 for fiscal year 1998, and such sums as may be
necessary for each of the fiscal years 1999 and 2000.'.
